Abbott's HUMIRA® Receives FDA Approval for Inhibiting Structural Joint Damage and Improving Physical Function in Patients with Arthritis
15th Nov 2006, 12:32 GMT
Abbott announced today that the U.S. Food and Drug Administration (FDA) approved an expanded indication for HUMIRA® (adalimumab) that includes inhibiting structural joint damage and improving physical function in patients with psoriatic arthritis (PsA). The expanded indication is in addition to the psoriatic arthritis approval granted in October 2005.HUMIRA is also approved in the U.S. [click link for full article]
Abbott's HUMIRA® Receives FDA Approval for Inhibiting Structural Joint Damage and Improving Physical Function in Patients with Arthritis related news:
- Abbott's HUMIRA Receives FDA Approval for Inhibiting Structural Joint Damage and Improving Physical Function in Patients With Psoriatic Arthritis — Government/ Industry Regulation News from StratCenter.com
- FDA Expands Use of Abbott's Humira — Government/ Industry Regulation News from StratCenter.com
- Abbott's Humira gets expanded indication — United Press International - Health Business
- Adalimumab Proves Effective For Children With Juvenile Rheumatoid Arthritis — Health News from Medical News Today
- Acupuncture helps ease discomfort in rheumatoid arthritis patients — NewKerala Health News
- Abbott's Humira Positive in 2 Studies — Operations-Related News from StratCenter.com
- Actemra™ Has A Major Impact On Improving Remission Rates In Rheumatoid Arthritis - 3 Studies From The Japanese Phase III Trial Programme — Health News from Medical News Today
- Repeat Treatment With MabThera Provides Continuous Improvement Of Quality Of Life In Rheumatoid Arthritis Patients — Health News from Medical News Today
- Trial Results Will Help In Treatment Of Arthritis — Health News from Medical News Today
- Rheumatoid Arthritis Patients Receiving Anti-TNF Therapy Can Be Effectively Immunized — Health News from Medical News Today
Latest news from Health News from Medical News Today:
- Biotech Industry Welcomes WHO Initiative On Naming Of Biologicals Including Biosimilar Medicines
- Common Cause Of Heart Disease, Diabetes May Be Treatable With Malaria Drug
- Two Nerve Cells In Direct Contact
- Value Of 'Helper' Compound In Treating Some Leukemias
- Internists Take Home Several National Awards At AAMC Annual Meeting
- Most Canadian Med School Grads Lack Basic Surgical Skills
- ACP's Electronic Medical Resource Ranked No. 1 Evidence-based Tool By MLA's South Central Chapter
- University Of Illinois Scientist Helping Processors Keep E. Coli Out Of Meat
- American Thoracic Society Publishes New Statement On Hepatotoxicity Of Antituberculosis Therapy
- Neural Networking Nanotubes